Welcome to Bright Roads
Investing in Clinical Data Science for a Brighter Future
Bright Roads is dedicated to strategic investment in clinical data science. As a home for companies building the future of data science for clinical trials, we create, support, and grow businesses that fuse technology, artificial intelligence, innovation, and patient-centered design to accelerate medical progress.
We’re investing in clinical data science to power what’s next.
Current Clinical Data Science Investments
Bright Roads rethinks how trials are run, how decisions are made, and how results improve lives. We’re currently investing in clinical data science through two companies. While one delivers uncompromising excellence in clinical data science and the other offers holistic statistical assessments of new treatments, they’re both focused on rigorous mathematical methods and innovation to better serve patients everywhere.
-
A globally recognized clinical data science partner, IDDI combines advanced biostatistics with strategic clinical trial design to maximize success and reduce risk in drug development. They support everything from early-stage planning to drug approval consulting and associated marketing service execution.
Take a Closer Look at IDDI -
Born from an internal innovation at IDDI, One2Treat delivers cutting-edge software solutions that use advanced data aggregation and modeling tools to integrate multiple meaningful dimensions in a treatment assessment, determining its overall medical value.
Learn More About One2Treat
The Road Ahead
Bright Roads is investing in clinical data science to unlock smarter, faster, and more effective healthcare solutions. Our portfolio reflects a growing commitment to life science investment and supporting bold thinkers who see what’s next — and build it.